"It seems to me therefore that the right test is whether there was a substantial chance that the creditors would not have approved the CVA in the form in which it was presented."
"It is well established that the scheme company has a duty to place before members of creditors sufficient information for them to make a reasonable judgment as to whether the scheme is in their commercial interest or not."
"If a creditor or member wishes to oppose a scheme or plan based upon a contention that the company's valuation evidence is the outcome for creditors or members and the relevant alternative is wrong, they must stop shouting from the spectators’ seats and step up to the plate. The creditor or member should obtain any financial information from the company that may be required, either on a voluntary basis or by making a timely disclosure application, file expert evidence of its own, instruct the expert to engage in the production of a joint report in the normal manner and tender the expert for cross-examination."
"It has been firmly established that although differential treatment to different groups of creditors is a cause for enquiry which needs to be justified, it is not inherently unfairly prejudicial."
"assets that would, in the relevant alternative, have been available for all unsecured creditors are allocated in a greater proportion to other creditors (for example, where critical creditors are paid in full), then the fact that the fact that the requisite majority was reached by reason of the votes of those creditors may point towards a CVA being unfairly prejudicial even if there was an objective justification for their payment in full."
"Each Critical Creditor shall be paid the full amount of its Allowed CVA claim by the Company direct."
"The amount payable to each Non-Critical Creditor shall be approximately 1.2 or 1.3% of the allowed CVA claim of the relevant Non-Critical Creditor."
"Estimated outcomes to Creditors of Mizen Properties Limited as at22nd April 2022 ."